MAGNESIUM SULFATE HEPTAHYDRATE

MAGNESIUM SULFATE HEPTAHYDRATE was reported 13182 times

MAGNESIUM SULFATE HEPTAHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 107 0.7643
1 VAGINAL FLATULENCE 154 0.5083
2 MITOCHONDRIAL DNA MUTATION 30 0.3488
3 NEONATAL INTESTINAL PERFORATION 12 0.3333
4 SCHIZENCEPHALY 11 0.2444
5 CEREBRAL HAEMORRHAGE FOETAL 11 0.1803
6 DELIVERY 108 0.1639
7 HYPERMAGNESAEMIA 104 0.1593
8 CSF OLIGOCLONAL BAND PRESENT 20 0.1538
9 BURKHOLDERIA TEST POSITIVE 16 0.1290
10 NEGATIVE PRESSURE PULMONARY OEDEMA 11 0.1122
11 FEMALE GENITAL TRACT FISTULA 163 0.0954
12 AIRWAY PEAK PRESSURE INCREASED 13 0.0855
13 PCO2 INCREASED 50 0.0702
14 NEUROMUSCULAR BLOCKADE 15 0.0670
15 RADICULOPATHY 165 0.0625
16 PO2 INCREASED 30 0.0592
17 RENAL ISCHAEMIA 32 0.0585
18 BLOOD MAGNESIUM INCREASED 51 0.0565
19 TACHYCARDIA FOETAL 28 0.0561
20 PROCTITIS 154 0.0549
21 CHRONIC SINUSITIS 206 0.0548
22 PROPOFOL INFUSION SYNDROME 38 0.0539
23 ADRENAL SUPPRESSION 45 0.0534
24 BLOOD GASES ABNORMAL 28 0.0519
25 NEUROMUSCULAR BLOCK PROLONGED 17 0.0461
26 APGAR SCORE LOW 56 0.0434
27 STATUS ASTHMATICUS 19 0.0403
28 MACULAR DEGENERATION 463 0.0387
29 RESPIRATORY TRACT INFECTION BACTERIAL 19 0.0382
30 ECLAMPSIA 14 0.0381
31 HELLP SYNDROME 23 0.0375
32 PLEOCYTOSIS 20 0.0344
33 BRADYCARDIA FOETAL 28 0.0337
34 BLOOD PH DECREASED 57 0.0333
35 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 16 0.0329
36 DIABETES INSIPIDUS 79 0.0328
37 LOW BIRTH WEIGHT BABY 258 0.0324
38 NEONATAL INFECTION 11 0.0318
39 MATERNAL EXPOSURE DURING DELIVERY 31 0.0313
40 FOETAL HEART RATE DECELERATION ABNORMALITY 21 0.0297
41 POSTPARTUM HAEMORRHAGE 38 0.0282
42 PREMATURE DELIVERY 428 0.0269
43 BLOOD BICARBONATE DECREASED 50 0.0264
44 MACROGLOSSIA 14 0.0255
45 PROSTATIC PAIN 10 0.0245
46 LUNG HYPERINFLATION 21 0.0244
47 PREMATURE BABY 686 0.0228
48 PRE-ECLAMPSIA 101 0.0212
49 URETERIC STENOSIS 17 0.0212
50 C-REACTIVE PROTEIN DECREASED 13 0.0199
51 FOETAL DISTRESS SYNDROME 41 0.0193
52 NEONATAL RESPIRATORY DISTRESS 18 0.0191
53 KLEBSIELLA TEST POSITIVE 12 0.0184
54 NEONATAL RESPIRATORY DISTRESS SYNDROME 65 0.0184
55 SACRAL PAIN 11 0.0181
56 AMNIOTIC CAVITY INFECTION 13 0.0180
57 TERMINAL ILEITIS 11 0.0179
58 PO2 DECREASED 20 0.0174
59 NEONATAL DISORDER 27 0.0170
60 FOETAL DEATH 88 0.0170
61 HYPOMAGNESAEMIA 236 0.0169
62 ENDOMETRITIS 11 0.0165
63 BRONCHOPULMONARY DYSPLASIA 13 0.0161
64 SEPSIS NEONATAL 13 0.0160
65 PARAESTHESIA ORAL 229 0.0159
66 VAGINAL DISCHARGE 158 0.0156
67 NEONATAL ASPHYXIA 11 0.0155
68 GENE MUTATION 30 0.0151
69 LYMPHOCELE 10 0.0151
70 DRUG-DISEASE INTERACTION 11 0.0150
71 PERINEAL PAIN 10 0.0140
72 RESPIRATORY ACIDOSIS 55 0.0140
73 PLACENTAL DISORDER 13 0.0137
74 BLOOD MAGNESIUM DECREASED 115 0.0133
75 CEREBRAL VENTRICLE DILATATION 15 0.0130
76 ORAL CANDIDIASIS 169 0.0128
77 GINGIVAL DISORDER 49 0.0127
78 TETANY 23 0.0126
79 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 74 0.0125
80 OXYGEN SATURATION ABNORMAL 35 0.0123
81 FUNGAL SEPSIS 10 0.0120
82 DRUG EXPOSURE VIA BREAST MILK 13 0.0119
83 HYPERCAPNIA 35 0.0116
84 TORSADE DE POINTES 90 0.0115
85 ABDOMINAL SEPSIS 10 0.0114
86 BLOOD UREA DECREASED 14 0.0113
87 HYPOTONIA NEONATAL 17 0.0109
88 KLEBSIELLA SEPSIS 12 0.0106
89 BLOOD LACTIC ACID INCREASED 56 0.0106
90 CYTOKINE RELEASE SYNDROME 213 0.0106
91 ELECTROENCEPHALOGRAM ABNORMAL 33 0.0104
92 PREMATURE SEPARATION OF PLACENTA 16 0.0104
93 PNEUMONIA KLEBSIELLA 19 0.0103
94 BREECH PRESENTATION 13 0.0103
95 PREMATURE LABOUR 58 0.0102
96 PRODUCT CONTAMINATION MICROBIAL 12 0.0101
97 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 14 0.0099
98 VITH NERVE PARALYSIS 11 0.0096
99 PATENT DUCTUS ARTERIOSUS 38 0.0096
100 INCISION SITE PAIN 11 0.0094
101 PNEUMOPERITONEUM 17 0.0092
102 MULTI-ORGAN FAILURE 156 0.0090
103 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 34 0.0089
104 FUNGAEMIA 14 0.0089
105 HYPOCALCAEMIA 168 0.0089
106 ISCHAEMIC HEPATITIS 12 0.0088
107 MATERNAL EXPOSURE DURING PREGNANCY 780 0.0087
108 FOETAL EXPOSURE DURING PREGNANCY 707 0.0087
109 NECROTISING COLITIS 11 0.0087
110 HYPERNATRAEMIA 43 0.0086
111 APLASTIC ANAEMIA 45 0.0086
112 RESPIRATORY TRACT INFECTION VIRAL 20 0.0086
113 LEFT VENTRICULAR DYSFUNCTION 57 0.0085
114 CAESAREAN SECTION 99 0.0085
115 PANCREATITIS CHRONIC 20 0.0084
116 STREPTOCOCCAL SEPSIS 10 0.0084
117 MYASTHENIA GRAVIS CRISIS 12 0.0081
118 ACUTE PULMONARY OEDEMA 45 0.0080
119 SMALL FOR DATES BABY 39 0.0078
120 HYPOREFLEXIA 15 0.0078
121 METHAEMOGLOBINAEMIA 18 0.0078
122 MULTIPLE-DRUG RESISTANCE 24 0.0077
123 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
124 CLONUS 21 0.0077
125 BRONCHIECTASIS 51 0.0076
126 SYSTEMIC CANDIDA 19 0.0076
127 HAEMODYNAMIC INSTABILITY 57 0.0075
128 EXPOSURE DURING PREGNANCY 456 0.0073
129 METABOLIC ENCEPHALOPATHY 22 0.0073
130 HEPARIN-INDUCED THROMBOCYTOPENIA 36 0.0073
131 ORAL DISORDER 53 0.0072
132 TOXIC EPIDERMAL NECROLYSIS 109 0.0072
133 PROCEDURAL PAIN 197 0.0071
134 BACTERIAL SEPSIS 23 0.0071
135 PREMATURE RUPTURE OF MEMBRANES 17 0.0070
136 BLOOD CHLORIDE DECREASED 18 0.0070
137 ACUTE RESPIRATORY FAILURE 134 0.0070
138 BLOOD ALBUMIN DECREASED 55 0.0069
139 STILLBIRTH 33 0.0068
140 LUNG CONSOLIDATION 19 0.0068
141 HYPERLACTACIDAEMIA 18 0.0067
142 LARYNGOSPASM 18 0.0067
143 HYPOALBUMINAEMIA 52 0.0067
144 PRODUCT PACKAGING CONFUSION 16 0.0066
145 PNEUMONIA STAPHYLOCOCCAL 13 0.0066
146 HYPOKALAEMIA 301 0.0065
147 ATELECTASIS 63 0.0065
148 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0065
149 HYPOPHOSPHATAEMIA 48 0.0065
150 FOETAL GROWTH RESTRICTION 39 0.0064
151 BLOOD CALCIUM DECREASED 72 0.0064
152 BLOOD CHLORIDE INCREASED 11 0.0064
153 COLITIS 239 0.0063
154 NEUTROPENIC SEPSIS 45 0.0063
155 VENTRICULAR TACHYCARDIA 104 0.0063
156 FREQUENT BOWEL MOVEMENTS 170 0.0063
157 NEUTROPENIC COLITIS 13 0.0063
158 BEHAVIOUR DISORDER 34 0.0063
159 TACHYPNOEA 85 0.0062
160 INTRA-UTERINE DEATH 10 0.0062
161 FAILURE TO THRIVE 32 0.0062
162 BACTERAEMIA 73 0.0061
163 STATUS EPILEPTICUS 69 0.0061
164 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 13 0.0061
165 FEBRILE NEUTROPENIA 402 0.0061
166 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
167 ENCEPHALOPATHY 146 0.0059
168 ACIDOSIS 45 0.0059
169 PROTEIN TOTAL DECREASED 22 0.0058
170 NEPHROGENIC ANAEMIA 27 0.0058
171 BLOOD PHOSPHORUS DECREASED 21 0.0057
172 RESPIRATORY RATE DECREASED 18 0.0057
173 URINE OUTPUT DECREASED 50 0.0057
174 FEAR 153 0.0057
175 DEVICE INFUSION ISSUE 14 0.0056
176 INTRAVENTRICULAR HAEMORRHAGE 14 0.0056
177 CYTOMEGALOVIRUS VIRAEMIA 25 0.0056
178 LIVE BIRTH 47 0.0056
179 CYTOMEGALOVIRUS TEST POSITIVE 10 0.0056
180 ADRENAL INSUFFICIENCY 68 0.0056
181 ELECTROCARDIOGRAM QT PROLONGED 201 0.0056
182 DERMATITIS ACNEIFORM 34 0.0056
183 ENTEROCOCCAL INFECTION 27 0.0056
184 BILIRUBIN CONJUGATED INCREASED 13 0.0056
185 STAPHYLOCOCCAL SEPSIS 27 0.0055
186 VENTRICULAR EXTRASYSTOLES 55 0.0053
187 HYPOPROTEINAEMIA 10 0.0053
188 MATERNAL DRUGS AFFECTING FOETUS 40 0.0052
189 SINUS TACHYCARDIA 74 0.0052
190 HYPERURICAEMIA 21 0.0051
191 BLOOD CREATININE DECREASED 16 0.0051
192 RENAL TUBULAR NECROSIS 50 0.0051
193 PNEUMONIA FUNGAL 20 0.0051
194 VENTRICULAR FIBRILLATION 56 0.0050
195 SUPRAVENTRICULAR EXTRASYSTOLES 17 0.0050
196 GRAFT VERSUS HOST DISEASE 36 0.0050
197 GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0050
198 ELECTROCARDIOGRAM T WAVE INVERSION 11 0.0050
199 NORMAL NEWBORN 27 0.0050
200 RESPIRATORY FAILURE 362 0.0050
201 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
202 VENTRICULAR ARRHYTHMIA 18 0.0049
203 PULMONARY OEDEMA 218 0.0049
204 ENTEROCOLITIS 28 0.0048
205 RECTAL HAEMORRHAGE 208 0.0048
206 TACHYARRHYTHMIA 12 0.0048
207 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
208 ANORGASMIA 13 0.0048
209 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
210 ACUTE RESPIRATORY DISTRESS SYNDROME 84 0.0047
211 INTESTINAL ISCHAEMIA 26 0.0047
212 BLOOD CULTURE POSITIVE 14 0.0047
213 CEREBROVASCULAR DISORDER 14 0.0046
214 ENDOTRACHEAL INTUBATION 13 0.0046
215 STAPHYLOCOCCAL BACTERAEMIA 20 0.0046
216 DRUG EXPOSURE DURING PREGNANCY 156 0.0046
217 ANHEDONIA 120 0.0046
218 RESPIRATORY DISTRESS 126 0.0046
219 HYPERBILIRUBINAEMIA 47 0.0045
220 ESCHERICHIA SEPSIS 13 0.0045
221 RENAL INJURY 133 0.0045
222 ELECTROLYTE IMBALANCE 52 0.0045
223 HYPOXIA 157 0.0045
224 STEM CELL TRANSPLANT 11 0.0044
225 HYPERKALAEMIA 154 0.0044
226 HYPERPARATHYROIDISM SECONDARY 11 0.0044
227 ACUTE GRAFT VERSUS HOST DISEASE 20 0.0044
228 APNOEA 34 0.0044
229 SINUS BRADYCARDIA 42 0.0043
230 ENCEPHALITIS 30 0.0043
231 SEPTIC SHOCK 188 0.0043
232 LUNG INFILTRATION 38 0.0043
233 BUNDLE BRANCH BLOCK LEFT 18 0.0042
234 INFUSION RELATED REACTION 279 0.0042
235 PNEUMATOSIS INTESTINALIS 12 0.0042
236 PULSE ABSENT 20 0.0042
237 PARTIAL SEIZURES 22 0.0042
238 FLUID OVERLOAD 61 0.0042
239 VASCULAR DEVICE INFECTION 19 0.0042
240 OLIGURIA 26 0.0042
241 BLOOD UREA INCREASED 70 0.0042
242 CLOSTRIDIAL INFECTION 14 0.0041
243 AREFLEXIA 11 0.0041
244 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 21 0.0041
245 STRIDOR 12 0.0041
246 ILEUS PARALYTIC 18 0.0040
247 AORTIC STENOSIS 14 0.0040
248 VARICES OESOPHAGEAL 12 0.0040
249 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
250 DIASTOLIC DYSFUNCTION 12 0.0039
251 METABOLIC ACIDOSIS 124 0.0039
252 CLOSTRIDIUM DIFFICILE COLITIS 41 0.0039
253 RIGHT VENTRICULAR FAILURE 27 0.0038
254 OESOPHAGITIS 42 0.0038
255 BLOOD CREATINE INCREASED 17 0.0038
256 RESPIRATORY RATE INCREASED 34 0.0038
257 ATRIAL SEPTAL DEFECT 32 0.0038
258 FLUID INTAKE REDUCED 19 0.0038
259 GESTATIONAL DIABETES 18 0.0038
260 GASTROINTESTINAL NECROSIS 11 0.0038
261 NYSTAGMUS 20 0.0038
262 RENAL FAILURE ACUTE 159 0.0037
263 HYDRONEPHROSIS 28 0.0037
264 SHOCK 86 0.0037
265 SEPSIS 417 0.0037
266 PROCTALGIA 24 0.0037
267 COLITIS ULCERATIVE 166 0.0037
268 LUMBAR VERTEBRAL FRACTURE 17 0.0037
269 THROMBOPHLEBITIS 13 0.0037
270 PULMONARY HAEMORRHAGE 29 0.0037
271 ILEUS 46 0.0037
272 HYPOVENTILATION 12 0.0037
273 SMALL INTESTINAL OBSTRUCTION 45 0.0037
274 TRICUSPID VALVE INCOMPETENCE 29 0.0036
275 HAEMATOCHEZIA 201 0.0036
276 TUMOUR LYSIS SYNDROME 32 0.0036
277 CARDIOGENIC SHOCK 52 0.0036
278 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 257 0.0036
279 BONE LESION 13 0.0036
280 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
281 DEVICE RELATED INFECTION 55 0.0036
282 BK VIRUS INFECTION 12 0.0036
283 PSEUDOMONAS INFECTION 30 0.0035
284 MALNUTRITION 39 0.0035
285 GENERALISED OEDEMA 43 0.0035
286 MATERNAL EXPOSURE TIMING UNSPECIFIED 13 0.0035
287 DECUBITUS ULCER 28 0.0034
288 PERIPHERAL ISCHAEMIA 14 0.0034
289 NEUROTOXICITY 60 0.0034
290 STUPOR 11 0.0034
291 TONGUE OEDEMA 13 0.0034
292 BONE EROSION 12 0.0034
293 MENTAL STATUS CHANGES 94 0.0034
294 RESPIRATORY ARREST 93 0.0034
295 UNRESPONSIVE TO STIMULI 87 0.0034
296 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
297 SUPRAVENTRICULAR TACHYCARDIA 32 0.0033
298 NORMOCHROMIC NORMOCYTIC ANAEMIA 10 0.0033
299 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
300 VENTRICULAR SEPTAL DEFECT 19 0.0033
301 COAGULOPATHY 55 0.0033
302 OLIGOHYDRAMNIOS 11 0.0033
303 RESPIRATORY DISORDER 98 0.0033
304 HYPERGLYCAEMIA 119 0.0033
305 NEUTROPHIL COUNT DECREASED 133 0.0033
306 ATRIAL FLUTTER 26 0.0033
307 CARDIAC ARREST 269 0.0033
308 HYPERVOLAEMIA 16 0.0032
309 BRONCHOPULMONARY ASPERGILLOSIS 25 0.0032
310 BRONCHOPNEUMONIA 11 0.0032
311 BONE DENSITY ABNORMAL 12 0.0032
312 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
313 MITRAL VALVE INCOMPETENCE 36 0.0032
314 PLEURAL EFFUSION 193 0.0032
315 PNEUMONIA VIRAL 10 0.0031
316 COVID-19 PNEUMONIA 37 0.0031
317 BLOOD POTASSIUM DECREASED 94 0.0031
318 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 53 0.0031
319 CUSHINGOID 10 0.0031
320 JAUNDICE CHOLESTATIC 11 0.0031
321 LOOSE TOOTH 10 0.0031
322 RENAL FAILURE 408 0.0031
323 WOUND SECRETION 12 0.0031
324 PNEUMONIA BACTERIAL 28 0.0030
325 PANCYTOPENIA 170 0.0030
326 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 29 0.0030
327 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 10 0.0030
328 PULMONARY HYPERTENSION 63 0.0030
329 HYPERTRANSAMINASAEMIA 21 0.0030
330 MUCOSAL INFLAMMATION 79 0.0030
331 BRONCHOSPASM 43 0.0030
332 RENAL IMPAIRMENT 253 0.0030
333 HAEMORRHAGE INTRACRANIAL 45 0.0030
334 PROTEIN URINE PRESENT 15 0.0030
335 CARDIOMEGALY 37 0.0030
336 CHOLECYSTITIS ACUTE 17 0.0030
337 ASCITES 88 0.0030
338 RENAL FAILURE CHRONIC 23 0.0030
339 ANAEMIA 568 0.0030
340 ABDOMINAL ABSCESS 13 0.0029
341 CARBOHYDRATE ANTIGEN 125 INCREASED 10 0.0029
342 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 22 0.0029
343 CYANOSIS 46 0.0029
344 BLOOD BILIRUBIN INCREASED 79 0.0029
345 HYPOTENSION 580 0.0029
346 LARGE INTESTINE PERFORATION 20 0.0029
347 INJURY 202 0.0029
348 THROMBOCYTOPENIA 318 0.0028
349 NECROTISING FASCIITIS 10 0.0028
350 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
351 ASPIRATION 31 0.0028
352 LEUKOCYTOSIS 51 0.0028
353 ASPARTATE AMINOTRANSFERASE INCREASED 149 0.0028
354 HYPOTONIA 28 0.0028
355 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
356 INTESTINAL PERFORATION 31 0.0028
357 AZOTAEMIA 11 0.0028
358 LACTIC ACIDOSIS 89 0.0027
359 PERIPHERAL SENSORY NEUROPATHY 16 0.0027
360 HAEMATOCRIT DECREASED 54 0.0027
361 KIDNEY TRANSPLANT REJECTION 13 0.0027
362 ACUTE KIDNEY INJURY 414 0.0027
363 HYPERCHOLESTEROLAEMIA 26 0.0027
364 BRAIN OEDEMA 34 0.0027
365 PERICARDIAL EFFUSION 62 0.0027
366 COLITIS ISCHAEMIC 18 0.0027
367 CARDIAC MURMUR 23 0.0027
368 EMBOLISM 22 0.0026
369 HEPATOMEGALY 26 0.0026
370 BLOOD CREATINE PHOSPHOKINASE INCREASED 76 0.0026
371 BREATH SOUNDS ABNORMAL 13 0.0026
372 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
373 TROPONIN INCREASED 20 0.0026
374 TACHYCARDIA 232 0.0026
375 LYMPHOCYTE COUNT DECREASED 46 0.0026
376 GRAND MAL CONVULSION 24 0.0026
377 ESCHERICHIA URINARY TRACT INFECTION 11 0.0026
378 MULTIPLE ORGAN DYSFUNCTION SYNDROME 73 0.0026
379 GASTRITIS EROSIVE 12 0.0026
380 RHINOVIRUS INFECTION 10 0.0026
381 DYSPEPSIA 252 0.0026
382 BLOOD CREATININE INCREASED 165 0.0025
383 PROTEINURIA 48 0.0025
384 OSTEOPENIA 38 0.0025
385 ENTERITIS 16 0.0025
386 ALANINE AMINOTRANSFERASE INCREASED 153 0.0025
387 PNEUMONIA ASPIRATION 62 0.0025
388 WHEELCHAIR USER 11 0.0025
389 HYPONATRAEMIA 139 0.0025
390 SERUM FERRITIN INCREASED 13 0.0025
391 HYPERCALCAEMIA 30 0.0024
392 PNEUMONITIS 66 0.0024
393 BLOOD PRESSURE SYSTOLIC DECREASED 11 0.0024
394 CYTOMEGALOVIRUS INFECTION 40 0.0024
395 HYPOVOLAEMIA 14 0.0024
396 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
397 UROSEPSIS 22 0.0024
398 LOCALISED OEDEMA 11 0.0024
399 MULTIPLE MYELOMA 11 0.0024
400 CARDIOTOXICITY 21 0.0024
401 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
402 SKIN LESION 64 0.0023
403 PYREXIA 806 0.0023
404 UNEVALUABLE EVENT 175 0.0023
405 HERPES SIMPLEX 15 0.0023
406 DRUG LEVEL INCREASED 38 0.0023
407 TRANSFUSION 24 0.0023
408 DUODENAL ULCER PERFORATION 17 0.0023
409 WOUND INFECTION 25 0.0023
410 GROIN PAIN 20 0.0023
411 CHOLECYSTITIS 27 0.0023
412 CARDIAC FAILURE ACUTE 15 0.0022
413 PLATELET COUNT DECREASED 240 0.0022
414 NEUTROPHIL COUNT INCREASED 23 0.0022
415 ATRIAL FIBRILLATION 218 0.0022
416 PRODUCT LABEL CONFUSION 13 0.0022
417 ABDOMINAL TENDERNESS 11 0.0022
418 STAPHYLOCOCCAL INFECTION 73 0.0022
419 SHOCK HAEMORRHAGIC 18 0.0022
420 RESPIRATORY DEPRESSION 27 0.0022
421 BRAIN INJURY 22 0.0022
422 WHITE BLOOD CELL COUNT ABNORMAL 14 0.0022
423 HYPERLIPIDAEMIA 26 0.0022
424 OXYGEN SATURATION DECREASED 122 0.0022
425 ENDOCARDITIS 11 0.0021
426 NEPHROPATHY TOXIC 24 0.0021
427 HYPOGAMMAGLOBULINAEMIA 14 0.0021
428 HEPATIC FAILURE 64 0.0021
429 BRADYCARDIA 112 0.0021
430 STRESS CARDIOMYOPATHY 12 0.0021
431 COMPRESSION FRACTURE 11 0.0021
432 THROMBOTIC MICROANGIOPATHY 20 0.0021
433 ABDOMINAL PAIN 474 0.0020
434 HYPOPHAGIA 52 0.0020
435 END STAGE RENAL DISEASE 37 0.0020
436 FLANK PAIN 19 0.0020
437 HYDROCEPHALUS 11 0.0020
438 PROTHROMBIN TIME PROLONGED 12 0.0020
439 EXTRASYSTOLES 14 0.0020
440 MIOSIS 16 0.0020
441 DELIRIUM 69 0.0020
442 GASTROENTERITIS 29 0.0020
443 DUODENAL ULCER 14 0.0020
444 MYASTHENIA GRAVIS 16 0.0020
445 NO THERAPEUTIC RESPONSE 24 0.0020
446 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 108 0.0020
447 HYPERTHERMIA 15 0.0020
448 BODY TEMPERATURE INCREASED 40 0.0020
449 DEHYDRATION 261 0.0020
450 APHASIA 59 0.0020
451 PERONEAL NERVE PALSY 11 0.0019
452 SPINAL COMPRESSION FRACTURE 16 0.0019
453 LUNG INFECTION 30 0.0019
454 HIATUS HERNIA 25 0.0019
455 BACTERIAL INFECTION 36 0.0019
456 WRONG PRODUCT ADMINISTERED 13 0.0019
457 MALABSORPTION 10 0.0019
458 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
459 PNEUMOTHORAX 30 0.0019
460 NEUTROPENIA 257 0.0019
461 HYPERTRIGLYCERIDAEMIA 11 0.0019
462 TRANSPLANT REJECTION 15 0.0019
463 BLOOD DISORDER 15 0.0019
464 C-REACTIVE PROTEIN INCREASED 68 0.0019
465 EJECTION FRACTION DECREASED 29 0.0019
466 ANAL ABSCESS 10 0.0019
467 PYELONEPHRITIS 16 0.0018
468 RASH MACULO-PAPULAR 41 0.0018
469 IRON DEFICIENCY ANAEMIA 17 0.0018
470 DRUG TOXICITY 25 0.0018
471 INTERNATIONAL NORMALISED RATIO INCREASED 52 0.0018
472 ESCHERICHIA INFECTION 15 0.0018
473 WHEEZING 108 0.0018
474 PULMONARY CONGESTION 24 0.0018
475 CONSTIPATION 394 0.0018
476 TRANSAMINASES INCREASED 40 0.0018
477 WRONG DRUG ADMINISTERED 16 0.0018
478 ARRHYTHMIA 85 0.0018
479 ANOREXIA 23 0.0018
480 STOMATITIS 108 0.0018
481 POST PROCEDURAL COMPLICATION 34 0.0018
482 DEPRESSED LEVEL OF CONSCIOUSNESS 70 0.0018
483 RENAL CYST 14 0.0018
484 CIRCULATORY COLLAPSE 30 0.0018
485 LIP SWELLING 58 0.0017
486 HEPATIC FUNCTION ABNORMAL 65 0.0017
487 OEDEMA 94 0.0017
488 BONE MARROW FAILURE 35 0.0017
489 RALES 10 0.0017
490 LEUKOPENIA 86 0.0017
491 SKIN WARM 10 0.0017
492 ANGIOEDEMA 76 0.0017
493 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
494 LIPASE INCREASED 13 0.0017
495 SUBDURAL HAEMATOMA 24 0.0017
496 DYSGRAPHIA 11 0.0017
497 GANGRENE 10 0.0017
498 OEDEMA PERIPHERAL 201 0.0016
499 PERITONITIS 34 0.0016
500 MEDICATION ERROR 91 0.0016
501 GASTRITIS 43 0.0016
502 POST PROCEDURAL HAEMORRHAGE 19 0.0016
503 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
504 ANURIA 14 0.0016
505 RHINITIS 13 0.0016
506 HEPATIC ENCEPHALOPATHY 15 0.0016
507 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
508 HYPOTHYROIDISM 51 0.0016
509 HYPERAESTHESIA 13 0.0016
510 HYPOTHERMIA 16 0.0016
511 BLOOD PRESSURE DECREASED 105 0.0016
512 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
513 WHITE BLOOD CELL COUNT INCREASED 60 0.0016
514 MYOSITIS 14 0.0016
515 HAEMOGLOBIN DECREASED 160 0.0016
516 PULMONARY TOXICITY 11 0.0016
517 ATRIOVENTRICULAR BLOCK 12 0.0016
518 CONGENITAL ANOMALY 12 0.0015
519 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
520 MELAENA 34 0.0015
521 PATHOGEN RESISTANCE 14 0.0015
522 RESPIRATORY TRACT INFECTION 40 0.0015
523 PNEUMONIA 496 0.0015
524 DRUG INTERACTION 242 0.0015
525 ASPERGILLUS INFECTION 10 0.0015
526 DEEP VEIN THROMBOSIS 99 0.0015
527 PSYCHOLOGICAL TRAUMA 13 0.0015
528 HAEMOPTYSIS 42 0.0015
529 MOUTH HAEMORRHAGE 11 0.0015
530 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
531 CELLULITIS 75 0.0015
532 EMPHYSEMA 15 0.0015
533 EMOTIONAL DISTRESS 180 0.0015
534 STEVENS-JOHNSON SYNDROME 33 0.0015
535 LIVER FUNCTION TEST ABNORMAL 43 0.0015
536 ACUTE MYELOID LEUKAEMIA 23 0.0015
537 ERYTHEMA 303 0.0015
538 ANAPHYLACTIC REACTION 81 0.0015
539 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
540 CARDIO-RESPIRATORY ARREST 61 0.0015
541 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
542 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
543 PETECHIAE 15 0.0014
544 DYSPNOEA EXERTIONAL 54 0.0014
545 CHILLS 168 0.0014
546 BLOOD SODIUM DECREASED 27 0.0014
547 ALTERED STATE OF CONSCIOUSNESS 31 0.0014
548 HAEMATOMA 37 0.0014
549 INTERSTITIAL LUNG DISEASE 69 0.0014
550 JOINT DISLOCATION 15 0.0014
551 DISABILITY 28 0.0014
552 CARDIAC FAILURE 113 0.0014
553 DIVERTICULUM 10 0.0014
554 CEREBRAL HAEMORRHAGE 50 0.0014
555 LETHARGY 80 0.0014
556 DISEASE RECURRENCE 66 0.0014
557 HEPATIC CIRRHOSIS 26 0.0014
558 ABORTION INDUCED 13 0.0014
559 SKIN LACERATION 15 0.0014
560 WEIGHT DECREASED 384 0.0014
561 SPINAL OSTEOARTHRITIS 12 0.0014
562 CARDIAC FAILURE CONGESTIVE 109 0.0014
563 BLOOD POTASSIUM INCREASED 22 0.0014
564 CHOLESTASIS 26 0.0014
565 CARDIOMYOPATHY 20 0.0014
566 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
567 CEREBRAL INFARCTION 33 0.0013
568 POLYURIA 11 0.0013
569 HAEMATURIA 46 0.0013
570 HICCUPS 11 0.0013
571 DIALYSIS 19 0.0013
572 WHITE BLOOD CELL COUNT DECREASED 145 0.0013
573 ORTHOSTATIC HYPOTENSION 23 0.0013
574 HAEMODIALYSIS 11 0.0013
575 PANCREATITIS 69 0.0013
576 PROCEDURAL COMPLICATION 10 0.0013
577 DYSURIA 48 0.0013
578 HYPOGLYCAEMIA 63 0.0013
579 FACIAL PARALYSIS 11 0.0013
580 ACUTE MYOCARDIAL INFARCTION 38 0.0013
581 THIRST 23 0.0013
582 PALLOR 35 0.0013
583 ANXIETY 366 0.0013
584 BLOOD GLUCOSE FLUCTUATION 14 0.0013
585 NEURALGIA 31 0.0013
586 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
587 MYOPATHY 11 0.0013
588 LYMPHOPENIA 18 0.0013
589 FURUNCLE 10 0.0013
590 MUSCULAR WEAKNESS 143 0.0013
591 ECONOMIC PROBLEM 19 0.0013
592 PRODUCT USE IN UNAPPROVED INDICATION 309 0.0012
593 GENERAL PHYSICAL HEALTH DETERIORATION 143 0.0012
594 DYSPHAGIA 117 0.0012
595 MUSCULOSKELETAL CHEST PAIN 19 0.0012
596 PULMONARY EMBOLISM 116 0.0012
597 CHOLELITHIASIS 40 0.0012
598 DEVELOPMENTAL DELAY 11 0.0012
599 NEUROPATHY PERIPHERAL 115 0.0012
600 MUSCLE INJURY 10 0.0012
601 SLEEP APNOEA SYNDROME 23 0.0012
602 SPLENOMEGALY 14 0.0012
603 DRUG ERUPTION 21 0.0012
604 HYPERTENSION 251 0.0012
605 GASTROINTESTINAL HAEMORRHAGE 99 0.0012
606 ERYTHEMA MULTIFORME 11 0.0012
607 THERAPY NON-RESPONDER 53 0.0012
608 TOOTH ABSCESS 12 0.0012
609 SUBARACHNOID HAEMORRHAGE 12 0.0012
610 CONFUSIONAL STATE 190 0.0012
611 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
612 ACUTE HEPATIC FAILURE 16 0.0012
613 ARTERIOSCLEROSIS 11 0.0012
614 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
615 INTESTINAL OBSTRUCTION 44 0.0012
616 URINARY TRACT INFECTION 199 0.0012
617 INFUSION SITE PAIN 15 0.0012
618 POISONING DELIBERATE 11 0.0012
619 METASTASES TO BONE 19 0.0012
620 PAIN 709 0.0012
621 VOMITING 541 0.0011
622 ASTHMA 130 0.0011
623 PULMONARY FIBROSIS 22 0.0011
624 ECZEMA 60 0.0011
625 FOLLICULITIS 12 0.0011
626 URINARY RETENTION 38 0.0011
627 ABDOMINAL DISTENSION 118 0.0011
628 SKIN ULCER 29 0.0011
629 CHRONIC KIDNEY DISEASE 85 0.0011
630 BODY TEMPERATURE DECREASED 11 0.0011
631 DYSARTHRIA 42 0.0011
632 DRUG DISPENSING ERROR 17 0.0011
633 CHEST PAIN 206 0.0011
634 LUPUS-LIKE SYNDROME 10 0.0011
635 LOSS OF CONSCIOUSNESS 141 0.0011
636 BONE DISORDER 20 0.0011
637 RESTLESSNESS 40 0.0011
638 DISEASE PROGRESSION 129 0.0011
639 CORONARY ARTERY DISEASE 33 0.0011
640 EOSINOPHILIA 19 0.0011
641 NAUSEA 857 0.0011
642 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 52 0.0011
643 DIABETIC KETOACIDOSIS 26 0.0011
644 DYSPNOEA 612 0.0011
645 HEPATIC STEATOSIS 20 0.0011
646 IMMUNODEFICIENCY 16 0.0011
647 APPENDICITIS 10 0.0011
648 SYNCOPE 107 0.0011
649 CYSTITIS 34 0.0011
650 TRANSIENT ISCHAEMIC ATTACK 36 0.0011
651 CONVULSION 61 0.0011
652 CANDIDA INFECTION 18 0.0011
653 MALAISE 466 0.0011
654 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 55 0.0011
655 WEIGHT FLUCTUATION 11 0.0011
656 SKIN IRRITATION 48 0.0010
657 DIVERTICULITIS 29 0.0010
658 FEELING HOT 64 0.0010
659 EPISTAXIS 78 0.0010
660 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
661 CONDITION AGGRAVATED 314 0.0010
662 MUSCLE ATROPHY 13 0.0010
663 AUTOIMMUNE DISORDER 10 0.0010
664 UPPER RESPIRATORY TRACT INFECTION 47 0.0010
665 BACK PAIN 236 0.0010
666 RED BLOOD CELL COUNT DECREASED 29 0.0010
667 DIARRHOEA 652 0.0010
668 RHABDOMYOLYSIS 42 0.0010
669 MYOCLONUS 12 0.0010
670 FEELING COLD 28 0.0010
671 ABSCESS 16 0.0010
672 GASTRIC ULCER 19 0.0010
673 PLATELET COUNT INCREASED 13 0.0010
674 MOUTH ULCERATION 21 0.0010
675 MALIGNANT NEOPLASM PROGRESSION 102 0.0010
676 FOOT DEFORMITY 11 0.0010
677 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
678 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
679 OFF LABEL USE 862 0.0010
680 DECREASED APPETITE 227 0.0010
681 HAEMORRHOIDS 19 0.0010
682 RIB FRACTURE 20 0.0010
683 LIVER DISORDER 43 0.0010
684 VAGINAL HAEMORRHAGE 42 0.0010
685 CHEST DISCOMFORT 99 0.0010
686 MYOCARDIAL ISCHAEMIA 11 0.0010
687 JAUNDICE 26 0.0010
688 HYPOKINESIA 14 0.0010
689 BLOOD PRESSURE ABNORMAL 19 0.0010
690 DERMATITIS ALLERGIC 12 0.0010
691 ASTHENIA 358 0.0010
692 INCONTINENCE 10 0.0009
693 OBESITY 15 0.0009
694 PULMONARY MASS 14 0.0009
695 OSTEOMYELITIS 17 0.0009
696 SKIN DISCOLOURATION 43 0.0009
697 MYDRIASIS 12 0.0009
698 FLUSHING 95 0.0009
699 LIVER FUNCTION TEST INCREASED 20 0.0009
700 DRUG INEFFECTIVE 1227 0.0009
701 NECK PAIN 52 0.0009
702 NEUROLEPTIC MALIGNANT SYNDROME 11 0.0009
703 RASH ERYTHEMATOUS 44 0.0009
704 OSTEOARTHRITIS 39 0.0009
705 TOXICITY TO VARIOUS AGENTS 155 0.0009
706 SEIZURE 106 0.0009
707 AGRANULOCYTOSIS 17 0.0009
708 METASTASES TO LIVER 16 0.0009
709 COLD SWEAT 16 0.0009
710 GASTROOESOPHAGEAL REFLUX DISEASE 73 0.0009
711 DENTAL CARIES 10 0.0009
712 OSTEOPOROSIS 37 0.0009
713 HYPERTENSIVE CRISIS 10 0.0009
714 DRUG RESISTANCE 23 0.0009
715 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
716 ORAL PAIN 20 0.0009
717 PERICARDITIS 15 0.0009
718 ANAPHYLACTIC SHOCK 23 0.0009
719 FISTULA 10 0.0009
720 CHROMATURIA 20 0.0009
721 POOR QUALITY SLEEP 19 0.0009
722 ULCER 14 0.0009
723 SEDATION 23 0.0009
724 BLOOD PRESSURE FLUCTUATION 21 0.0009
725 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
726 METASTASES TO LUNG 10 0.0009
727 TREMOR 143 0.0009
728 MUSCULOSKELETAL PAIN 45 0.0009
729 INFECTION 124 0.0009
730 HEART RATE DECREASED 30 0.0009
731 AGITATION 62 0.0008
732 BLOOD IRON DECREASED 10 0.0008
733 ISCHAEMIC STROKE 15 0.0008
734 COMA 40 0.0008
735 HEART RATE INCREASED 83 0.0008
736 RENAL DISORDER 39 0.0008
737 SOMNOLENCE 168 0.0008
738 SEROTONIN SYNDROME 16 0.0008
739 TYPE 2 DIABETES MELLITUS 28 0.0008
740 MYELODYSPLASTIC SYNDROME 12 0.0008
741 PRODUCT PREPARATION ERROR 17 0.0008
742 HEMIPARESIS 14 0.0008
743 DEPRESSION 188 0.0008
744 MUSCLE TWITCHING 19 0.0008
745 PRESYNCOPE 20 0.0008
746 DYSPHONIA 48 0.0008
747 BLISTER 46 0.0008
748 LIVER INJURY 20 0.0008
749 CEREBROVASCULAR ACCIDENT 138 0.0008
750 PAIN IN JAW 23 0.0008
751 PALPITATIONS 95 0.0008
752 SKIN DISORDER 27 0.0008
753 DISORIENTATION 32 0.0008
754 GINGIVAL BLEEDING 11 0.0008
755 PANCREATITIS ACUTE 18 0.0008
756 AMNESIA 52 0.0008
757 ABDOMINAL PAIN LOWER 20 0.0008
758 COORDINATION ABNORMAL 11 0.0008
759 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
760 RASH GENERALISED 20 0.0008
761 BLOOD PRESSURE INCREASED 118 0.0008
762 BURNING SENSATION 54 0.0008
763 PARAESTHESIA 121 0.0008
764 PARALYSIS 11 0.0008
765 DRUG-INDUCED LIVER INJURY 24 0.0008
766 DYSSTASIA 22 0.0008
767 HAEMATEMESIS 19 0.0007
768 PREGNANCY 15 0.0007
769 CARDIOVASCULAR DISORDER 19 0.0007
770 FOOT FRACTURE 14 0.0007
771 COLON CANCER 11 0.0007
772 FAECES DISCOLOURED 16 0.0007
773 IMPAIRED HEALING 24 0.0007
774 MULTIPLE FRACTURES 12 0.0007
775 LOWER LIMB FRACTURE 14 0.0007
776 SLEEP DISORDER 51 0.0007
777 HYPERHIDROSIS 93 0.0007
778 GASTROENTERITIS VIRAL 13 0.0007
779 HEPATOTOXICITY 16 0.0007
780 ORAL HERPES 14 0.0007
781 GLOSSODYNIA 16 0.0007
782 TREATMENT NONCOMPLIANCE 39 0.0007
783 ANKLE FRACTURE 11 0.0007
784 MOBILITY DECREASED 51 0.0007
785 HEADACHE 445 0.0007
786 LYMPHADENOPATHY 25 0.0007
787 CONJUNCTIVITIS 13 0.0007
788 FALL 233 0.0007
789 HAEMORRHAGE 73 0.0007
790 DRUG INTOLERANCE 67 0.0007
791 COUGH 193 0.0007
792 HYPOAESTHESIA 103 0.0007
793 BLOOD CHOLESTEROL INCREASED 32 0.0007
794 JOINT STIFFNESS 18 0.0007
795 CONTUSION 66 0.0007
796 LOWER RESPIRATORY TRACT INFECTION 31 0.0007
797 RASH 297 0.0007
798 EMOTIONAL DISORDER 21 0.0007
799 URTICARIA 114 0.0007
800 INCREASED APPETITE 13 0.0007
801 EAR INFECTION 18 0.0007
802 DRUG WITHDRAWAL SYNDROME NEONATAL 10 0.0007
803 HEPATIC ENZYME INCREASED 46 0.0007
804 LUNG DISORDER 33 0.0007
805 PRODUCT PRESCRIBING ERROR 16 0.0007
806 EAR PAIN 13 0.0007
807 HEPATITIS 17 0.0007
808 HEART RATE IRREGULAR 15 0.0007
809 TOOTHACHE 12 0.0007
810 ERECTILE DYSFUNCTION 17 0.0007
811 RESTLESS LEGS SYNDROME 12 0.0007
812 MUSCLE SPASMS 121 0.0007
813 GAIT INABILITY 22 0.0007
814 ACCIDENTAL OVERDOSE 24 0.0007
815 INTENTIONAL OVERDOSE 42 0.0007
816 TINNITUS 30 0.0007
817 FACE OEDEMA 11 0.0007
818 PRESCRIBED UNDERDOSE 13 0.0007
819 NERVOUSNESS 34 0.0007
820 OROPHARYNGEAL PAIN 60 0.0006
821 ABASIA 16 0.0006
822 WOUND 18 0.0006
823 PSYCHOTIC DISORDER 19 0.0006
824 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
825 URINARY INCONTINENCE 19 0.0006
826 NERVOUS SYSTEM DISORDER 20 0.0006
827 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
828 RHINORRHOEA 41 0.0006
829 NEOPLASM PROGRESSION 22 0.0006
830 PRODUCTIVE COUGH 30 0.0006
831 SCIATICA 10 0.0006
832 DERMATITIS 13 0.0006
833 DYSGEUSIA 46 0.0006
834 COVID-19 108 0.0006
835 FATIGUE 476 0.0006
836 LABORATORY TEST ABNORMAL 18 0.0006
837 RETCHING 13 0.0006
838 FLUID RETENTION 31 0.0006
839 RASH PRURITIC 33 0.0006
840 OSTEONECROSIS OF JAW 15 0.0006
841 PANIC ATTACK 22 0.0006
842 THROAT IRRITATION 27 0.0006
843 PRURITUS GENERALISED 13 0.0006
844 VIRAL INFECTION 20 0.0006
845 FUNGAL INFECTION 20 0.0006
846 FLATULENCE 34 0.0006
847 POLLAKIURIA 25 0.0006
848 DIZZINESS 298 0.0006
849 MENTAL DISORDER 26 0.0006
850 BLOOD GLUCOSE ABNORMAL 11 0.0006
851 ILL-DEFINED DISORDER 36 0.0006
852 ABDOMINAL PAIN UPPER 121 0.0006
853 PHOTOPHOBIA 11 0.0006
854 THROMBOSIS 47 0.0006
855 SCAR 10 0.0006
856 MUSCULOSKELETAL DISCOMFORT 10 0.0006
857 BLOOD URINE PRESENT 11 0.0006
858 DYSKINESIA 23 0.0006
859 PLASMA CELL MYELOMA 22 0.0006
860 GOUT 10 0.0006
861 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
862 SINUS DISORDER 11 0.0006
863 EYE DISORDER 18 0.0005
864 FEEDING DISORDER 11 0.0005
865 BLOOD GLUCOSE DECREASED 26 0.0005
866 WEIGHT INCREASED 121 0.0005
867 SWELLING FACE 35 0.0005
868 INSOMNIA 142 0.0005
869 HALLUCINATION 40 0.0005
870 BRONCHITIS 39 0.0005
871 NEPHROLITHIASIS 24 0.0005
872 CRYING 19 0.0005
873 THROAT TIGHTNESS 14 0.0005
874 SPEECH DISORDER 27 0.0005
875 JOINT INJURY 11 0.0005
876 COGNITIVE DISORDER 24 0.0005
877 INTENTIONAL PRODUCT USE ISSUE 45 0.0005
878 MIGRAINE 49 0.0005
879 VERTIGO 31 0.0005
880 ABDOMINAL DISCOMFORT 85 0.0005
881 ABNORMAL BEHAVIOUR 20 0.0005
882 CARDIAC DISORDER 47 0.0005
883 GAIT DISTURBANCE 96 0.0005
884 DIPLOPIA 13 0.0005
885 PAIN IN EXTREMITY 146 0.0005
886 MENTAL IMPAIRMENT 12 0.0005
887 FIBROMYALGIA 12 0.0005
888 DISCOMFORT 30 0.0005
889 MYALGIA 83 0.0005
890 HYPOACUSIS 21 0.0005
891 MEMORY IMPAIRMENT 67 0.0005
892 HERPES ZOSTER 28 0.0005
893 PRODUCT SUBSTITUTION ISSUE 28 0.0005
894 INFLUENZA LIKE ILLNESS 40 0.0005
895 DIABETES MELLITUS 36 0.0005
896 TREATMENT FAILURE 39 0.0005
897 IRRITABLE BOWEL SYNDROME 10 0.0005
898 NIGHT SWEATS 15 0.0005
899 DEMENTIA 13 0.0005
900 DEATH 397 0.0005
901 SWELLING 43 0.0005
902 RASH MACULAR 16 0.0005
903 BLOOD GLUCOSE INCREASED 86 0.0005
904 LOCALISED INFECTION 11 0.0005
905 ANGINA PECTORIS 13 0.0005
906 HYPERSOMNIA 13 0.0005
907 MYOCARDIAL INFARCTION 79 0.0005
908 VISION BLURRED 62 0.0005
909 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
910 DISTURBANCE IN ATTENTION 24 0.0004
911 ARTHRITIS 35 0.0004
912 INFLUENZA 49 0.0004
913 HOT FLUSH 33 0.0004
914 VISUAL IMPAIRMENT 54 0.0004
915 MUSCULOSKELETAL STIFFNESS 38 0.0004
916 LACRIMATION INCREASED 13 0.0004
917 EYE SWELLING 16 0.0004
918 BONE PAIN 25 0.0004
919 PRURITUS 164 0.0004
920 OVERDOSE 92 0.0004
921 OSTEONECROSIS 14 0.0004
922 EPILEPSY 13 0.0004
923 AGGRESSION 21 0.0004
924 SINUSITIS 43 0.0004
925 HEAD INJURY 13 0.0004
926 PERIPHERAL SWELLING 63 0.0004
927 PAIN OF SKIN 11 0.0004
928 HIP FRACTURE 13 0.0004
929 ARTHRALGIA 168 0.0004
930 ALOPECIA 79 0.0004
931 DRY EYE 20 0.0004
932 DRUG ADMINISTRATION ERROR 12 0.0004
933 MYELOSUPPRESSION 14 0.0004
934 LIMB DISCOMFORT 12 0.0004
935 FEMUR FRACTURE 12 0.0004
936 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
937 ROAD TRAFFIC ACCIDENT 16 0.0004
938 DEAFNESS 10 0.0004
939 JOINT SWELLING 46 0.0004
940 SKIN EXFOLIATION 32 0.0004
941 BALANCE DISORDER 32 0.0004
942 PSORIATIC ARTHROPATHY 15 0.0004
943 ILLNESS 38 0.0004
944 NASOPHARYNGITIS 66 0.0004
945 NASAL CONGESTION 21 0.0004
946 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
947 CATARACT 21 0.0004
948 IRRITABILITY 21 0.0003
949 INFLAMMATION 18 0.0003
950 GASTROINTESTINAL DISORDER 31 0.0003
951 MOVEMENT DISORDER 11 0.0003
952 HYPERSENSITIVITY 63 0.0003
953 DRY MOUTH 27 0.0003
954 PRODUCT USE ISSUE 62 0.0003
955 THERAPEUTIC RESPONSE DECREASED 20 0.0003
956 FEELING ABNORMAL 79 0.0003
957 HOSPITALISATION 50 0.0003
958 INCORRECT DOSE ADMINISTERED 73 0.0003
959 BONE DENSITY DECREASED 10 0.0003
960 NEOPLASM MALIGNANT 21 0.0003
961 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
962 SURGERY 18 0.0003
963 ARTHROPATHY 17 0.0003
964 DEPRESSED MOOD 16 0.0003
965 EYE PAIN 17 0.0003
966 OCULAR HYPERAEMIA 14 0.0003
967 MULTIPLE SCLEROSIS 14 0.0003
968 GASTRIC DISORDER 10 0.0003
969 SUICIDE ATTEMPT 17 0.0003
970 RHEUMATOID ARTHRITIS 31 0.0003
971 ADVERSE EVENT 25 0.0003
972 BLINDNESS 11 0.0003
973 LUNG NEOPLASM MALIGNANT 10 0.0002
974 INTENTIONAL PRODUCT MISUSE 20 0.0002
975 DRY SKIN 30 0.0002
976 DRUG WITHDRAWAL SYNDROME 19 0.0002
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
978 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
979 DRUG ABUSE 17 0.0002
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
981 ADVERSE DRUG REACTION 17 0.0002
982 NO ADVERSE EVENT 34 0.0002
983 DEVICE MALFUNCTION 13 0.0002
984 PSORIASIS 24 0.0002
985 PRODUCT DOSE OMISSION ISSUE 50 0.0002
986 INJECTION SITE ERYTHEMA 21 0.0002
987 DRUG DOSE OMISSION 23 0.0001
988 COMPLETED SUICIDE 11 0.0001
989 ACNE 10 0.0001
990 SUICIDAL IDEATION 12 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
992 PRODUCT QUALITY ISSUE 14 0.0001
993 INJECTION SITE PAIN 30 0.0001
994 DRUG DEPENDENCE 13 0.0001